• Biocartis launches Idylla™ GeneFusion Assay as rapid lab workflow solution for gene fusion testing

    Monday March 22nd 2021

  • Augustine Therapeutics strengthens Board of Directors and sets up Scientific Advisory Board

    Friday March 19th 2021

  • reMYND appoints Dr. Lode Debrabandere as Chief Business Officer

    Thursday March 18th 2021

  • FOx BIOSYSTEMS launches the White FOx, its new generation biosensor with fiber-optic surface plasmon resonance

    Thursday March 18th 2021

  • Augustine Therapeutics appoints Sylvain Celanire as CEO to accelerate development of innovative medicines for rare neuromuscular diseases

    Thursday March 18th 2021

  • eTheRNA extends leadership team with the appointment of Dr. Volker Germaschewski as Senior Vice President for R&D

    Thursday March 11th 2021

  • Complix signs global drug discovery and development agreement with I-Mab to develop cell penetrating alphabodies against two intracellular immuno-oncology targets

    Thursday March 11th 2021

  • AgomAb Therapeutics kondigt $74 miljoen series-B financiering aan

    Wednesday March 10th 2021

  • Your news here?

  • VIB announces complete development of COVID-19 antibody, and its effectiveness against new variants

    Wednesday March 10th 2021

  • Mithra and Searchlight Pharma announce Estelle® approval in Canada

    Monday March 8th 2021

  • Cardiology prepared for fourth dimension

    Friday March 5th 2021


Strategic Partners